Published in Mediators Inflamm on January 01, 2000
Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue-damaging activities. Protein Sci (2003) 1.01
A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning. Biochem J (2003) 0.91
Cell adhesion molecules involved in the leukocyte recruitment induced by venom of the snake Bothrops jararaca. Mediators Inflamm (2002) 0.79
Pharmacological characterisation of arthritis induced by Bothrops jararaca venom in rabbits: a positive cross talk between bradykinin, nitric oxide and prostaglandin E2. Mediators Inflamm (2002) 0.76
A serine protease isolated from the bristles of the Amazonic caterpillar, Premolis semirufa, is a potent complement system activator. PLoS One (2015) 0.75
Effects of PI and PIII Snake Venom Haemorrhagic Metalloproteinases on the Microvasculature: A Confocal Microscopy Study on the Mouse Cremaster Muscle. PLoS One (2016) 0.75
Biological characterization of compounds from Rhinella schneideri poison that act on the complement system. J Venom Anim Toxins Incl Trop Dis (2015) 0.75
Bothrops snake venoms and their isolated toxins, an L-amino acid oxidase and a serine protease, modulate human complement system pathways. J Venom Anim Toxins Incl Trop Dis (2015) 0.75
The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med (1962) 23.03
Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med (1973) 14.88
Leukocyte-endothelial interactions. Blood (1985) 5.59
Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest (1961) 3.63
The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol (1994) 2.54
Molecular and cellular mechanisms of leukocyte chemotaxis. Science (1981) 2.07
Phospholipase A2 myotoxins from Bothrops snake venoms. Toxicon (1995) 1.56
Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation (1993) 1.12
Structure and function of adhesion receptors in leukocyte trafficking. Immunol Today (1995) 1.07
Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon (1995) 1.00
Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway. J Immunol (1995) 0.99
A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon (1989) 0.99
Pro-inflammatory activities in elapid snake venoms. Br J Pharmacol (1994) 0.96
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. Agents Actions (1989) 0.94
The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study. Toxicon (1994) 0.93
Blister formation and skin damage induced by BaP1, a haemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Int J Exp Pathol (1998) 0.93
The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper. Arch Biochem Biophys (1990) 0.92
Leukocyte response induced by Bothrops jararaca crude venom: in vivo and in vitro studies. Toxicon (1997) 0.92
Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo). Toxicon (1998) 0.90
Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice. Toxicon (1995) 0.88
Skeletal muscle necrosis and regeneration after injection of BaH1, a hemorrhagic metalloproteinase isolated from the venom of the snake Bothrops asper (Terciopelo). Exp Mol Pathol (1995) 0.88
Purification and characterization of BaH4, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Toxicon (2000) 0.86
Lipoxygenase-derived mediators may be involved in in vivo neutrophil migration induced by Bothrops erythromelas and Bothrops alternatus venoms. Toxicon (1993) 0.86
[Myonecrosis, hemorrhage and edema induced by bothrops asper venom in white mice (author's transl)]. Toxicon (1980) 0.85
Pharmacological profile of rat pleurisy induced by Bothrops jararaca venom. J Pharm Pharmacol (1996) 0.84
In vitro studies on complement inactivation by snake venoms. Toxicon (1980) 0.84
Inflammatory infiltrate in skeletal muscle injected with Bothrops asper venom. Rev Biol Trop (1986) 0.83
Isolation and characterization of synergistic hemorrhagins from the venom of the snake Bothrops asper. Toxicon (1993) 0.83
[Alterations in the coagulation mechanisms of patients bitten by Bothrops asper (Terciopelo)]. Toxicon (1985) 0.78
Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie (2000) 1.60
Expression of complement in the brain: role in health and disease. Immunol Today (1996) 1.53
Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon (2010) 1.50
Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol (2007) 1.47
Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp Neurol (1999) 1.32
Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol (1997) 1.27
Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis. Am J Pathol (2000) 1.27
Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action. Cell Mol Life Sci (2008) 1.15
Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle Nerve (2003) 1.15
Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp Neurol (2000) 1.13
Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol (2000) 1.10
Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins. Int Rev Neurobiol (2007) 1.07
Myotoxic phospholipases A(2) in bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu. Biochimie (2000) 1.05
Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms. Toxicon (2000) 1.04
Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom. Arch Biochem Biophys (2001) 1.04
Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A(2) homologue from Bothrops neuwiedi pauloensis venom. Arch Biochem Biophys (2000) 1.02
Identification of residues critical for toxicity in Clostridium perfringens phospholipase C, the key toxin in gas gangrene. Eur J Biochem (2000) 1.02
Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA. Am J Trop Med Hyg (2001) 1.02
Effect of Trypanosoma cruzi membrane components on the formation of the classical pathway C3 convertase. Braz J Med Biol Res (1986) 1.00
Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom. Toxicon (1998) 1.00
Differential expression of individual complement regulators in the brain and choroid plexus. Lab Invest (1999) 0.99
Comparative study of the cytolytic activity of myotoxic phospholipases A2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro. Toxicon (1999) 0.99
A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon (1989) 0.99
The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review. Int J Inflam (2010) 0.99
[Presence of Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae) in Serra da Bodoquena, State of Mato Grosso do Sul, Brazil]. Rev Soc Bras Med Trop (2001) 0.97
The role of complement in disorders of the nervous system. Immunopharmacology (1997) 0.97
Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon (1985) 0.96
Structural and functional characterization of myotoxin I, a Lys49 phospholipase A(2) homologue from Bothrops moojeni (Caissaca) snake venom. Arch Biochem Biophys (2000) 0.96
Local effects induced by coral snake venoms: evidence of myonecrosis after experimental inoculations of venoms from five species. Toxicon (1983) 0.95
Calcium ion independent membrane leakage induced by phospholipase-like myotoxins. Biochemistry (1992) 0.95
Snakebite mortality in Costa Rica. Toxicon (1997) 0.95
Structure-function studies of the receptors for complement C1q. Biochem Soc Trans (2002) 0.94
Isolation of a myotoxin from Bothrops asper venom: partial characterization and action on skeletal muscle. Toxicon (1984) 0.94
Role of complement in the aetiology of Pick's disease? J Neuropathol Exp Neurol (1996) 0.94
Blister formation and skin damage induced by BaP1, a haemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Int J Exp Pathol (1998) 0.93
Immunoglobulin and cytokine expression in mixed lymphocyte cultures is reduced by disruption of gap junction intercellular communication. FASEB J (2001) 0.92
Crystal structure of myotoxin II, a monomeric Lys49-phospholipase A2 homologue isolated from the venom of Cerrophidion (Bothrops) godmani. Arch Biochem Biophys (1999) 0.92
Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (Terciopelo) snake venom. Exp Mol Pathol (1995) 0.91
Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production. Toxicon (1994) 0.91
Structure of a Lys49-phospholipase A2 homologue isolated from the venom of Bothrops nummifer (jumping viper). Toxicon (1999) 0.90
Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo). Toxicon (1998) 0.90
Effects of aqueous extract of Casearia sylvestris (Flacourtiaceae) on actions of snake and bee venoms and on activity of phospholipases A2. Comp Biochem Physiol B Biochem Mol Biol (2000) 0.89
Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy. Toxicon (2013) 0.89
Endothelial cells, megakaryoblasts, platelets and alveolar epithelial cells express abundant levels of the mouse AA4 antigen, a C-type lectin-like receptor involved in homing activities and innate immune host defense. Eur J Immunol (2001) 0.89
Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice. Toxicon (1995) 0.88
The effect of myotoxins isolated from Bothrops snake venoms on multilamellar liposomes: relationship to phospholipase A2, anticoagulant and myotoxic activities. Biochim Biophys Acta (1991) 0.88
Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I. Eur J Immunol (1995) 0.88
C3A binds to the seven transmembrane anaphylatoxin receptor expressed by epithelial cells and triggers the production of IL-8. FEBS Lett (2001) 0.88
[Neutralization of the hemorrhagic effect induced by Bothrops asper (Serpentes: Viperidae) venom with tropical plant extracts]. Rev Biol Trop (1999) 0.87
Skeletal muscle regeneration after myonecrosis induced by crude venom and a myotoxin from the snake Bothrops asper (Fer-de-Lance). Toxicon (1984) 0.87
Susceptibility of different strains of mice to South American rattlesnake (Crotalus durissus terrificus) venom: correlation between lethal effect and creatine kinase release. Toxicon (1991) 0.87
Complement classical pathway expression by human skeletal myoblasts in vitro. Mol Immunol (1997) 0.86
Characterization of the local tissue damage induced by LHF-II, a metalloproteinase with weak hemorrhagic activity isolated from Lachesis muta muta snake venom. Toxicon (1999) 0.86
Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants. Toxicon (2003) 0.86
Purification and characterization of BaH4, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Toxicon (2000) 0.86
Expression and function of membrane regulators of complement on rat astrocytes in culture. Immunology (1996) 0.86
Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo. Toxicon (2001) 0.86
Role of complement in inflammation and injury in the nervous system. Exp Clin Immunogenet (1997) 0.85
Pharmacological activities of a toxic phospholipase A isolated from the venom of the snake Bothrops asper. Comp Biochem Physiol C (1986) 0.85
Calcium imaging of muscle cells treated with snake myotoxins reveals toxin synergism and presence of acceptors. Cell Mol Life Sci (2009) 0.85
Specific heterologous F(ab')2 antibodies revert blood incoagulability resulting from envenoming by Lonomia obliqua caterpillars. Am J Trop Med Hyg (2001) 0.85
Effects of chemical modifications of crotoxin B, the phospholipase A(2) subunit of crotoxin from Crotalus durissus terrificus snake venom, on its enzymatic and pharmacological activities. Int J Biochem Cell Biol (2001) 0.85
p-Bromophenacyl bromide modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2, affects its pharmacological activities. Toxicon (1993) 0.85
Ultrastructural alterations in mouse capillary blood vessels after experimental injection of venom from the snake Bothrops asper (Terciopelo). Exp Mol Pathol (1992) 0.85
Pathological changes induced by BaH1, a hemorrhagic proteinase isolated from Bothrops asper (Terciopelo) snake venom, on mouse capillary blood vessels. Toxicon (1994) 0.85
Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes. Brain Res Mol Brain Res (1997) 0.85
Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper. Exp Mol Pathol (1984) 0.85
Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake bothrops asper. Biochem Pharmacol (2000) 0.85
Expression of a functional anaphylatoxin C3a receptor by astrocytes. J Neurochem (1998) 0.85
[Myonecrosis, hemorrhage and edema induced by bothrops asper venom in white mice (author's transl)]. Toxicon (1980) 0.85
Isolation and characterization of basic myotoxic phospholipases A2 from Bothrops godmani (Godman's pit viper) snake venom. Arch Biochem Biophys (1992) 0.85
Skeletal muscle necrosis and regeneration after injection of Thalassophryne nattereri (niquim) fish venom in mice. Int J Exp Pathol (2001) 0.84
First report of vancomycin-resistant Enterococcus faecium isolated in Argentina. Clin Infect Dis (1998) 0.84
Pathogenesis of myonecrosis induced by coral snake (Micrurus nigrocinctus) venom in mice. Br J Exp Pathol (1986) 0.84
Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets. J Infect (2012) 0.83
The Caenorhabditis elegans genome: a multifractal analysis. Genet Mol Res (2010) 0.83
Molecular and immunochemical evidences demonstrate that endooligopeptidase A is the predominant cytosolic oligopeptidase of rabbit brain. Biochem Biophys Res Commun (2000) 0.83
Comparison of the biological activities in venoms from three subspecies of the South American rattlesnake (Crotalus durissus terrificus, C. durissus cascavella and C. durissus collilineatus) Comp Biochem Physiol C Pharmacol Toxicol Endocrinol (1999) 0.83
Quantitation of myonecrosis induced by myotoxin a from prairie rattlesnake (Crotalus viridis viridis) venom. Toxicon (1982) 0.83
Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venom. Toxicon (2001) 0.83
Molecular and cellular properties of the rat AA4 antigen, a C-type lectin-like receptor with structural homology to thrombomodulin. J Biol Chem (2000) 0.83
A randomized double-blind clinical trial of two antivenoms in patients bitten by Bothrops atrox in Colombia. The Regional Group on Antivenom Therapy Research (REGATHER). Trans R Soc Trop Med Hyg (1997) 0.83
An MTT-based method for the in vivo quantification of myotoxic activity of snake venoms and its neutralization by antibodies. J Immunol Methods (1993) 0.83
Elapid venom toxins: multiple recruitments of ancient scaffolds. Eur J Biochem (1999) 0.83
Characterization of alpha-neurotoxin and phospholipase A2 activities from Micrurus venoms. Determination of the amino acid sequence and receptor-binding ability of the major alpha-neurotoxin from Micrurus nigrocinctus nigrocinctus. Eur J Biochem (1996) 0.83
Organochlorine residues in tissues of striped dolphins affected by the 1990 Mediterranean epizootic: relationships with the fatty acid composition. Arch Environ Contam Toxicol (1996) 0.83
Isolation and characterization of synergistic hemorrhagins from the venom of the snake Bothrops asper. Toxicon (1993) 0.83
Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom. Toxicon (1997) 0.82
Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon (2000) 0.82
[Mechanism of action of myotoxins isolated from snake venoms]. Rev Biol Trop (1984) 0.82
Development of an antivenom against toxins of Lonomia obliqua caterpillars. Toxicon (1996) 0.82
Sex-linked variation of Loxosceles intermedia spider venoms. Toxicon (1999) 0.82